In a murine NAFLD-HCC model, loss of hepatocyte FBP1, a gluconeogenic enzyme, induces HSC activation via HMGB1, followed by the release of senescence-associated secretome components such as IL-6 and CXCL1, promoting liver tumor growth [91]. This evidence concerns the gene HMGB1 and hepatocellular carcinoma.